Nom du produit:1-Isopropylpyrimidine-2,4,6(1H,3H,5H)-trione

IUPAC Name:1-(propan-2-yl)-1,3-diazinane-2,4,6-trione

CAS:69998-14-7
Formule moléculaire:C7H10N2O3
Pureté:95%+
Numéro de catalogue:CM337821
Poids moléculaire:170.17

Unité d'emballage Stock disponible Prix($) Quantité
CM337821-100mg in stock ŴŴƙ
CM337821-250mg in stock ǧƙŴ
CM337821-1g in stock ȦƀɅ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:69998-14-7
Formule moléculaire:C7H10N2O3
Point de fusion:-
Code SMILES:O=C1NC(CC(N1C(C)C)=O)=O
Densité:
Numéro de catalogue:CM337821
Poids moléculaire:170.17
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Pyrimidines
Pyrimidine, also known as 1,3-diazobenzene, is a heterocyclic compound with the chemical formula C4H4N2. Pyrimidine is formed by substituting 2 nitrogen atoms for 2 carbons in the meta-position of benzene. It is a diazine and retains its aromaticity. Derivatives of pyrimidine widely exist in organic macromolecular nucleic acids, and many drugs also contain pyrimidine rings. In nucleic acids, three nucleobases are pyrimidine derivatives: cytosine, thymine and uracil. There are a variety of pyrimidine-containing drugs on the market, most of which are kinase inhibitors.

Column Infos

Mavacamten
CAMZYOS(Mavacamten) was recently approved in the European Union, following its approval in the U.S. and other markets worldwide, and is the first and only cardiac myosin inhibitor approved to treat adult patients with symptomatic obstructive hypertrophic cardiomyopathy(HCM).
Mavacamten is a first-in-class, targeted inhibitor of cardiac myosin, reduces the number of myosin-actin cross-bridges and thus decreases excessive contractility characteristic of HCM.